All public logs

Combined display of all available logs of Beacon. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

18:17, 28 November 2023 Francine talk contribs created page Data Dictionary: Compilation: Department of Health Databases (CSO) (Created page with "{| class="wikitable" |+ Data on discharge, diagnostics, and procedures for inpatients |- | Age-Standardised Data for Principal Procedure |- | Age-Standardised Morbidity Rate for Principal Procedures |- | In-Patient and Daycase Principal Procedures and Average Length of Hospital Stay |- | Hospital Discharges of In-Patients, Daycases and Length of Stay (All Procedures) |- | Hospital Discharges of In-Patients, Daycases and Length of Stay (National Data - All Procedures) |-...")
18:13, 28 November 2023 Woloski talk contribs created page Institut du Cancer de Montpellier Trials (Created page with "'''NCTID''': NCT00875667 '''Title''': A Study to Determine the Efficacy of Lenalidomide Versus Investigator’s Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL) '''Study Summary''': To evaluate the safety and efficacy of lenalidomide versus investigator choice in patients with relapsed or refractory mantle cell lymphoma. '''Sponsor''': Celgene '''Intervention''': Lenalidomide '''Start Date''': 2009-04-30 '''Last Updated''': 2019-09-16...")
18:09, 28 November 2023 Woloski talk contribs created page Comprehensive Cancer Center Jean Perrin Trials (Created page with "'''NCTID''': NCT01491737 '''Title''': A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer '''Study Summary''': This randomized, open-label, two-arm, multi-center, Phase II study will evaluate the efficacy and safety of pertuzumab in combination with trastuzumab plus an aromatase inhibitor (AI) in f...")
18:03, 28 November 2023 Woloski talk contribs created page Cancer Institute Strasbourg Europe Trials (Created page with "'''NCTID''': NCT04717414 '''Title''': An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions '''Study Summary''': The purpose of this Phase 3 study is to evaluate the efficacy and safety of Luspatercept compared with placebo in subjects with myeloproliferative neoplasm (MPN)-associated Myelofibrosis (MF...")
17:55, 28 November 2023 Woloski talk contribs created page Gustave Roussy Trials (Created page with "'''NCTID''': NCT02666690 '''Title''': Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast '''Study Summary''': RECIST criteria for evaluating tumor response are often inadequate for the evaluation of anti-angiogenic drugs. An evaluation model of tumor perfusion with contrast-enhanced ultrasonography was developed at Gustave Roussy. It assesses the tumor vascular response through the analysis of 7...")
17:52, 28 November 2023 Woloski talk contribs created page Eugène Marquis Cancer Centre Trials (Created page with "'''NCTID''': NCT02444000 '''Title''': gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas '''Study Summary''': Patients with 1p/19q-codeleted anaplastic gliomas treated with RT + PCV are at risk of neurocognitive deterioration. Treating these patients with PCV alone (could reduce the risk of neurocognitive deterioration without impairing overall survival. '''Sponsor''': Assistance Publique - Hôpitaux de Paris '''Intervention''': PCV chemotherapy alone '''St...")
17:48, 28 November 2023 Woloski talk contribs created page Institut de Cancérologie de l'Ouest (ICO) - Integrated Center for Oncology Trials (Created page with "'''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabine alone, in patients with metastatic Pancreatic Ductal Adenocarcinoma (PDAC) after FOLFIRINOX failure or intolerance. '''Sponsor''': UNICANCER ''...")
17:44, 28 November 2023 Woloski talk contribs created page APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC) Trials (Created page with "'''NCTID''': NCT04622319 '''Title''': A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) '''Study Summary''': Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy are at higher risk of disease recurrence. More effective treatment options ar...")
17:10, 28 November 2023 Francine talk contribs created page Cancer Areas of Interest: I.Stat - Smoking Habits (Created page with "{| class="wikitable" |+ Cancers and Diagnoses ! ICD-10 Code !! Diagnoses |- | C00-C14 || Cancers of the oral cavity and pharynx |- | C15 || Cancer of the esophagus |- | C16 || Cancer of the stomach |- | C18-C21 || Cancers of the colon and rectum |- | C22 || Cancer of the liver |- | C25 || Cancer of the pancreas |- | C32 || Cancer of the larynx |- | C33-C34 || Cancers of the lung, bronchus, and trachea |- | C64-C65 || Cancers of the kidney and renal pelvis |- | C67 || Can...")
17:08, 28 November 2023 Woloski talk contribs created page Centre François Baclesse Trials (Created page with "'''NCTID''': NCT01827943 '''Title''': Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer '''Study Summary''': In the absence of standard treatment in this indication, this test evaluates a new drug type targeted therapy in this indication, evaluating its efficacy in terms of tumor response and survival. '''Sponsor''': Institut Bergonié '''Intervention''': Temsirolimus '''Start Date''': 2009-06 '''Last Updated''...")
16:59, 28 November 2023 Francine talk contribs created page Cancer Areas of Interest: I.Stat - Causes of Death (Created page with "{| class="wikitable" |+ Malignant Neoplasms and Diagnoses ! ICD-10 Code !! Diagnoses |- | C00-C14 || Malignant neoplasm of lip, oral cavity, and pharynx |- | C15 || Malignant neoplasm of esophagus |- | C16 || Malignant neoplasm of stomach |- | C18-C21 || Malignant neoplasm of colon, rectum, and anus |- | C22 || Malignant neoplasm of liver |- | C25 || Malignant neoplasm of pancreas |- | C32 || Malignant neoplasm of larynx |- | C33-C34 || Malignant neoplasm of trachea, bro...")
16:42, 28 November 2023 Woloski talk contribs created page University Cancer Institute Toulouse-Oncopole Trials (Created page with "'''NCTID''': NCT06112314 '''Title''': IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) '''Study Summary''': This is a phase 3, randomized, controlled study of IMC-F106C plus nivolumab compared to standard nivolumab regimens in HLA-A*02:01-positive participants with previously untreated advanced melanoma. '''Sponsor''': Immunocore Ltd '''Intervention''': IMC-F106C '''Start Date''': 2023-12-01 '''Last Updated...")
15:52, 28 November 2023 Woloski talk contribs created page Institut Paoli-Calmettes Trials (Created page with "'''NCTID''': NCT04070443 '''Title''': Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase '''Study Summary''': The investigators hypothesize that, in newly diagnosed de novo chronic phase CML patients, an induction treatment with ponatinib for 6 months should increase the rate of patients reaching a stable MR4.5 allowing cessation of imatinib treatment. The investigators proposal is to conduct a multicen...")
01:23, 28 November 2023 Woloski talk contribs created page Institut Curie Trials (Created page with "'''NCTID''': NCT03875573 '''Title''': Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: '''Study Summary''': Neo-CheckRay is a multicenter, open-label phase II study that randomizes luminal B breast cancer subjects candidate for neo-adjuvant chemotherapy in a 1:1:1 ratio in 3 arms: 1. the combination of weekly paclitaxel followed by dose-dense doxorubicin-cyclophospham...")
01:16, 28 November 2023 Woloski talk contribs created page Léon Bérard Center Trials (Created page with "'''NCTID''': NCT03525392 '''Title''': Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. '''Study Summary''': This study was being conducted to advance new treatment for patients with metastatic or locally advanced cancers expressing Neurotensin receptor 1 (NTSR1). This study was a first administration of a radioactive drug called 177Lu-3BP-227 to patients under cont...")
00:42, 28 November 2023 Woloski talk contribs created page File:Latvia female.png
00:42, 28 November 2023 Woloski talk contribs uploaded File:Latvia female.png
00:38, 28 November 2023 Woloski talk contribs created page File:Latvia all.png
00:38, 28 November 2023 Woloski talk contribs uploaded File:Latvia all.png
22:31, 27 November 2023 Woloski talk contribs created page Oulu University Hospital Trials (Created page with "'''NCTID''': NCT04607421 '''Title''': A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer '''Study Summary''': The purpose of this study is to evaluate two study medicines (encorafenib plus cetuximab) taken alone or together with standard chemotherapy for the potential treatment of colorectal cancer that: * has spread to other parts of the body (metastatic); * has a certain type of abnorma...")
22:26, 27 November 2023 Woloski talk contribs created page Cancer Center of Kuopio University Hospital Trials (Created page with "'''NCTID''': NCT04597125 '''Title''': Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH '''Study Summary''': Researchers in this study want to compare how well drug radium-223 dichloride (Xofigo) and new (novel) anti-hormonal...")
20:57, 27 November 2023 Woloski talk contribs created page TAYS Cancer Centre Tampere University Hospital Trials (Created page with "'''NCTID''': NCT04736706 '''Title''': A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012) '''Study Summary''': The goal of this study is to evaluate the efficacy and safety of pembrolizumab plus belzutifan plus lenvatinib or pembrolizumab/qua...")
20:44, 27 November 2023 Woloski talk contribs created page Turku University Hospital Cancer Centre Trials (Created page with "'''NCTID''': NCT03486873 '''Title''': Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) '''Study Summary''': The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this extension study. This s...")
15:03, 27 November 2023 Francine talk contribs created page Cancer Areas of Interest: Hospital Discharge Database (SDO) (Created page with "Source: [https://www.salute.gov.it/imgs/C_17_pubblicazioni_3277_allegato.pdf]. {| class="wikitable" |+ ICD-10 Codes and Diagnoses ! ICD-10 Code !! Diagnoses |- | C67 || Malignant bladder tumors |- | C50 || Malignant breast tumors |- | C77-C79 || Secondary malignant tumors (These codes represent secondary and unspecified malignant neoplasms) |- | D48 || Other and unspecified benign tumors (This is the code for neoplasms of uncertain or unknown behavior) |- | C34 || Malig...")
23:37, 24 November 2023 Woloski talk contribs created page Helsinki University Hospital Comprehensive Cancer Center Trials (Created page with "'''NCTID''': NCT05173987 '''Title''': Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15) '''Study Summary''': The purpose of this study is to assess the safety and efficacy of treatment with pembrolizumab (MK-3475) compared to a combination of carboplatin and paclitaxel in women with mismatch repair deficient (dMMR) advanced or recurrent end...")
22:22, 24 November 2023 Woloski talk contribs created page East Tallinn Central Hospital Trials (Created page with "'''NCTID''': NCT05152147 '''Title''': A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers '''Study Summary''': This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better than trastuzumab given with chemotherapy. The patients in this study will have advanced human epidermal growth...")
20:48, 24 November 2023 Woloski talk contribs created page North Estonia Medical Centre Trials (Created page with "<nowiki>'''</nowiki>NCTID<nowiki>'''</nowiki>: NCT02205047 <nowiki>'''</nowiki>Title<nowiki>'''</nowiki>: Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma <nowiki>'''</nowiki>Study Summary<nowiki>'''</nowiki>: The purpose of this study is to find out whether either trastuzumab or the combination of trastuzumab and pertuzumab with standard chemotherapy shows more activity against gastro-oesophageal...") Tag: Visual edit
20:38, 24 November 2023 Woloski talk contribs created page Tartu University Hospital Trials (Created page with "'''NCTID''': NCT04241185 '''Title''': Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) '''Study Summary''': This study is designed to assess the antitumor efficacy and safety of pembrolizumab in combination with chemoradiotherapy (CRT) versus CRT alone in participants with muscle-invasive bladder cancer (MIBC). The primary hypothesis is that pem...") Tag: Visual edit: Switched
20:30, 24 November 2023 Woloski talk contribs created page Vejle Cancer Centre – The Patients’ Cancer Hospital part of Lillebaelt Hospital Trials (Created page with "'''NCTID''': NCT05573022 '''Title''': Impact of a Patient Decision Aid Intervention '''Study Summary''': Studies evaluating decisions aids have used a wide range of outcome measures as well as formats and settings. Most studies have focused on patient decision aids used either within the consultation or delivered pre-consultation, but there are no randomised, controlled studies comparing the two. However, timing and format of the patient decision aid intervention may...")
20:02, 24 November 2023 Francine talk contribs created page Cancer Areas of Interest: Cancer Registry (Created page with "{| class="wikitable" |+ ICD-10 Codes and Diagnoses ! ICD-10 Code !! Diagnosis |- | C00-C96 || Malignant neoplasms |- | C00 || Lip |- | C01-C14 || Malignant neoplasms of oral cavity and pharynx |- | C01 || Base of tongue |- | C15 || Malignant neoplasm of esophagus |- | C16 || Malignant neoplasm of stomach |- | C18 || Malignant neoplasm of colon |- | C19-C21 || Malignant neoplasms of rectosigmoid junction, rectum, and anus |- | C19 || Rectosigmoid junction |- | C22 || Mali...")
17:08, 24 November 2023 Francine talk contribs created page Cancer Areas of Interest: National Register of Cancer (RNC) (Created page with "All primary in situ and invasive tumors are recorded, except for non-melanoma skin cancers. For benign tumors or tumors with uncertain evolution, only the following tumors are recorded: *Benign tumors with uncertain evolution of the central nervous system (C70, C71 et C72) and intracerebral endocrine glands (C75.1 - C75.5); *Thymomas (C37.9); *Ovarian's borderline tumors (C56.9); *Invasive hydatidiform mole (placenta tumor) (C58.9); *pTa non-invasive papillary carcin...")
17:48, 23 November 2023 Larysse talk contribs created page Data dictionary: Cyprus Cancer Registry (Created page with "Go back to Republic of Cyprus page Source: [https://www.moh.gov.cy/moh/moh.nsf/All/D6C382E728E5320FC22579C600265CDE/$file/MECC%20Manual%20of%20Coding%20and%20Staging%205.1%20July%202009.pdf] {| class="wikitable" ! Cancer Registry Data |- | Mecc Registry Identification Number |- | Registry Patient Number |- | Sequence Number |- | Patient’s Name |- | Patient’s National Identity Number |- | Age at Diagnosis |- | Date of Birth |- | Sex |- | Marital Status (at Diagn...")
17:16, 23 November 2023 Larysse talk contribs created page Cancer Areas of Interest: Cyprus Cancer Registry (Created page with "Go back to Republic of Cyprus page Source: [https://www.moh.gov.cy/moh/moh.nsf/All/459D2F001BD17FBFC22579C60026616A/$file/Cyprus%20Cancer%20Registry%20Progress%20Report,%20August%202016%20(Data%202011-2013).pdf] {| class="wikitable" ! ICD Code !! Diagnosis |- | C00 || Lip |- | C01-C02 || Tongue |- | C03-C06 || Mouth |- | C07-C08 || Salivary glands |- | C09 || Tonsil |- | C10 || Other Oropharynx |- | C11 || Nasopharynx |- | C12-C13 || Hypopharynx |- | C14 || Pharynx...")
11:22, 23 November 2023 Larysse talk contribs created page Data Dictionary: Central Health Information System (Created page with "Go back to Croatia page Source:[http://www.cezih.hr/dts_rezultati_i_novosti.html] {| class="wikitable" ! 25 most common categories by hospital |- | Healthcare institution code |- | Name of the health care institution |- | Number of invoices issued |- | Average duration of hospitalization |- | Average cost for materials |- | Average cost for medicines |- | The average cost for the rest (medical work and board) is borne by the Institute |- | Average age of hospitaliz...")
21:44, 22 November 2023 Woloski talk contribs created page Motol University Hospital Trials (Created page with "'''NCTID''': NCT02447666 '''Title''': Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML) '''Study Summary''': Indication Treatment of pediatric subjects with newly diagnosed advanced myelodysplastic syndrome (MDS) or juvenile myelomonocytic leukemia (JMML) prior to hematopoietic stem cell transplantation (HSCT). Objectives Primary Objective The primary objective is to...")
21:01, 22 November 2023 Woloski talk contribs created page Kortrijk Cancer Centre AZ Groeninge Trials (Created page with "'''NCTID''': NCT01332968 '''Title''': A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) '''Study Summary''': This open-label, randomized study will assess the efficacy and safety of obinutuzumab (RO5072759) in combination with chemotherapy compared to rituximab (MabThera/Rituxan) with chemothe...")
19:45, 22 November 2023 Francine talk contribs created page Data Dictionary: Oncobarómetro (Created page with "{| class="wikitable" |- | Subjective assessment of health status in the last twelve months | Type of healthy life | Health advice on various issues | Frequency in following health advice | Expectation of cure for a series of diseases | Areas of health research in which to make greater efforts in the future | Degree of severity of different health problems in Spain | Illness or situation that causes you the most fear | Reasons why an illness or situation makes you more af...")
17:08, 22 November 2023 Francine talk contribs created page Cancer Areas of Interest: Cancer Incidence in Portugal (Created page with "{| class="wikitable" |- ! ICD-10 Code !! Diagnoses |- | C00-C14 || Oral cavity and pharynx |- | C15-C26 || Peritoneum and digestive organs |- | C30-C39 || Respiratory system and intrathoracic organs |- | C40-C49 || Hematopoietic system and endothelial reticulum |- | C50-C58, C60-C63, C64-C68 || Genito-urinary organs |- | C50 || Breast |- | C69 || Eye and lacrimal gland |- | C70-C72 || Nervous system |- | C73-C75 || Endocrine glands |- | C47-C49 || Soft tissue |- | C77 ||...")
17:00, 22 November 2023 Francine talk contribs created page Cancer Areas of Interest: Cancer Survival and Incidence in the Central Region of Portugal (Created page with "Source: List is available on page 3 of the document [https://ron.min-saude.pt/media/2073/publicação-2010.pdf]. {| class="wikitable" |- ! ICD-10 Code !! Diagnoses |- | C00 || Lip |- | C01 || Base of tongue |- | C02 || Other and unspecified parts of the tongue |- | C03 || Gum |- | C04 || Floor of mouth |- | C05 || Palate |- | C06 || Other and unspecified parts of the mouth |- | C07 || Parotid gland |- | C08 || Other and unspecified major salivary glands |- | C09 || Tons...")
16:30, 22 November 2023 Francine talk contribs created page Cancer Areas of Interest: Cancer Incidence, Survival and Mortality in the Southern Region of Portugal (ISM) (Created page with "Source: The list can be checked on page 25 of the document [https://ron.min-saude.pt/media/2200/ror_sul_ism_2016_17.pdf]. {| class="wikitable" |- ! ICD-10 Code ! Diagnoses |- | C01 || Base of tongue |- | C02 || Other and unspecified parts of the tongue |- | C03 || Gum |- | C04 || Floor of mouth |- | C05 || Palate |- | C06 || Other and unspecified parts of the mouth |- | C07 || Parotid gland |- | C08 || Other and unspecified major salivary glands |- | C09 || Tonsil |- |...")
22:53, 21 November 2023 Woloski talk contribs created page Masaryk Memorial Cancer Institute Trials (Created page with "'''NCTID''': NCT05603351 '''Title''': Prostate Cancer Screening With Abbreviated MRI Protocol '''Study Summary''': Prostate cancer is one of the most common malignancies in the male population with incidence and mortality rates comparable to breast cancer in women, but in contrast, a population screening program that would fulfill all the recommended criteria is not yet available. According to international recommendations, the preventive PSA sampling used in clinical...")
21:34, 21 November 2023 Woloski talk contribs created page University Hospital for Tumors of Zagreb Trials (Created page with "’‘’NCTID’’‘: NCT00117572 ’‘’Title’’‘: Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) ’‘’Study Summary’’‘: The combined use of chemotherapeutic drugs with radiation has proven to be effective in improving overall survival and local control among patients with locally advanced head and neck cancer. Induction chemotherapy given before receiving local treatment has be...") Tag: Visual edit
20:26, 21 November 2023 Francine talk contribs created page Cancer Areas of Interest: Hospital Morbidity Data Base (Created page with "{| class="wikitable" |- ! Cancer Areas of Interest |- | Lymphatic malignancies and/or other malignancies and/or neoplasms of uncertain behavior |- | Major procedures in BO for lymph nodes/hematopoietic organs or other |- | Malignant diseases of the ear, nose, mouth, throat, head/face |- | Malignant diseases of the kidney and/or urinary tract |- | Procedures in the kidney and/or urinary tract, due to malignant diseases |- | Malignant diseases of the male reproductive syst...")
11:36, 21 November 2023 Francine talk contribs created page Available Variables: Cervical Cancer Screening Registry ZORA (Created page with "'''Data on monitoring and evaluation: 3-year examination coverage by:''' *Year *Age group *Territorial unit *No. of examined women *No. of women with permanent residence, and transparency '''Citology results:''' *Number of all screening smears satisfactory for evaluation and screening results stratified by calendar years '''HPV triage test:''' *Number of all HPV triage test by calendar years and indication for the test '''Histopatology:''' *Number of all invasive...")
11:19, 21 November 2023 Francine talk contribs created page Patient Association: Europa Donna – Slovenian association for the fight against breast cancer (Slovenia) (Created page with "'''Primary purpose:''' To support and advocate for comprehensive care, early detection, and awareness of breast and genital cancer, while also promoting a healthy lifestyle and patients' rights. '''Contact Information:''' Information [https://europadonna.si/kontakti/].")
11:18, 21 November 2023 Francine talk contribs created page Patient Association: The Association of Oncology Patients of Slovenia (Slovenia) (Created page with "'''Primary purpose:''' To support and advocate for cancer patients, promote holistic treatment, provide voluntary assistance, disseminate knowledge about cancer and health, emphasize active patient participation in treatment and rehabilitation, and protect patients' rights. '''Contact Information:''' Information [https://www.onkologija.org/o-drustvu/osebna-izkaznica-kontakt/].")
21:42, 20 November 2023 Francine talk contribs created page Available Type of Information: DORA Breast Cancer Screening Registry (Created page with "{| class="wikitable" |- ! Available variables |- | Regional unit |- | Year |- | Age group |- | Screening round number |- | Number of women pictured |- | Number of women invited to mammography |- | Participation in the DORA programme |- | Conference consensus |- | Number of women on additional treatments |- | Number of breast cancers detected |- | Number of screening centers in operation |- | Proportion of invited women who attended screening mammography |- | Proportion o...")
17:22, 20 November 2023 Francine talk contribs created page Available Variables: Database: NIJZ Records on Diseases, Poisonings and Injuries on Hospitals (BOLOB) (Created page with "{| class="wikitable" |- ! Available variables |- | Number of hospitalizations due to illness |- | Gender |- | Year |- | Statistical region |- | Age group |- | Main diagnoses |- | ICD-10 |- | Number of first and re-admissions to hospitals |- | Number of hospitalizations due to injuries and poisoning |- | Reason for hospital treatment |- | External cause |- | Number of deaths |- | Number of hospitalizations due to accidental injuries and poisoning |- | Number of hospitaliz...")
17:19, 20 November 2023 Francine talk contribs created page Available Type of Information: (Created page with "{| class="wikitable" |- ! Available variables |- | Number of hospitalizations due to illness |- | Gender |- | Year |- | Statistical region |- | Age group |- | Main diagnoses |- | ICD-10 |- | Number of first and re-admissions to hospitals |- | Number of hospitalizations due to injuries and poisoning |- | Reason for hospital treatment |- | External cause |- | Number of deaths |- | Number of hospitalizations due to accidental injuries and poisoning |- | Number of hospitaliz...")
17:16, 20 November 2023 Francine talk contribs created page Available Type of Information: Database: NIJZ Records on Diseases, Poisonings and Injuries on Hospitals (BOLOB) (Created page with "{| class="wikitable" |- ! Available variables |- | Number of hospitalizations due to illness |- | Gender |- | Year |- | Statistical region |- | Age group |- | Main diagnoses |- | ICD-10 |- | Number of first and re-admissions to hospitals |- | Number of hospitalizations due to injuries and poisoning |- | Reason for hospital treatment |- | External cause |- | Number of deaths |- | Number of hospitalizations due to accidental injuries and poisoning |- | Number of hospitaliz...")